Scientists use a protein found in mucus membranes to ferry vaccines to the lymph nodes.

Rheumatologist Song Guo Zheng pleaded guilty in November to delivering US-funded research to China.

Vaccines against various forms of cancer prime the immune system to attack.

Researchers devise strategies to improve checkpoint inhibitor therapy and predict patient response.

Researchers identify signatures that predict how a person will respond to an immune system stimulus.

Surveillance Gaps: How Cancer Arises

Death rates among blood cancer patients who contract COVID-19 are higher than for those with other cancers, pointing to impaired immunity that makes it hard to overcome the virus.

Industry and academic leaders will describe how small immune cell subsets shape the human immune response.

Outcomes in COVID-19 patients may be better in those recently infected with endemic coronaviruses. 

Researchers propose that an infusion of memory T cells from people who have recovered from SARS-CoV-2 infections could treat severe disease.

Infusions of donor T cells to fight the cancer often fail, but sodium bicarbonate can counter lactic acid produced by leukemia cells, potentially improving remission rates in mice and humans.

Discover how researchers are using flow cytometry to delve into the inner workings of the immune life cycle!

Experts will discuss their research on SARS-CoV-2 antibody persistence and immune memory in recovered COVID-19 patients and the implications for protective immunity.

Conversations between the immune and central nervous systems are proving to be essential for the healthy social behavior, learning, and memory.

Several routes exist for immune cells to communicate with neurons in the central nervous system, though T cells rarely come in direct contact with neural tissue.

The rare complication known as multisystem inflammatory syndrome in children (MIS-C) differs from both Kawasaki disease and severe adult cases of COVID-19, a study finds.

An absence of germinal centers—which arise during infections to produce long-lived antibody-generating cells—might explain rapidly waning antibody levels in the disease.

There are emerging signs that some people might have heightened protection against SARS-CoV-2, perhaps thanks to recent infection by other coronaviruses.

A B-cell receptor critical for the production of a subset of intestinal antibodies has been pinpointed, but the function of those antibodies remains unclear.